NYSE:NSPR
InspireMD Inc Stock News
$2.00
-0.0100 (-0.498%)
At Close: May 03, 2024
NSPR Stock: Why It Increased Today
06:19pm, Wednesday, 13'th Oct 2021
The stock price of InspireMD Inc (NASDAQ: NSPR) increased by over 5% today. This is why it happened.
InspireMD Receives Reimbursement Approval for CGuard™ Embolic Prevention System from the French National Authority for Health
08:30am, Wednesday, 13'th Oct 2021
TEL AVIV, Israel, Oct. 13, 2021 (GLOBE NEWSWIRE) -- InspireMD, Inc. (Nasdaq: NSPR), a global developer of the CGuard™ Embolic Prevention Stent System (EPS) device for the treatment of Carotid Artery
2 Net Current Asset Value Stock Picks to Consider
12:39pm, Monday, 27'th Sep 2021
There are some investors who purchase U.S.-listed stocks that are trading below their liquidation values because they believe they can get a huge return out of these stocks after the market has reappr
InspireMD, Inc. (NSPR) CEO Marvin Slosman on Q2 2021 Results - Earnings Call Transcript
11:56am, Tuesday, 10'th Aug 2021
InspireMD, Inc. (NSPR) CEO Marvin Slosman on Q2 2021 Results - Earnings Call Transcript
InspireMD Announces Strong Second Quarter 2021 Financial Results
07:00am, Tuesday, 10'th Aug 2021
Revenue rebound, strong procedural recovery
InspireMD Enrolls and Treats First Patients at Ballad Health System in U.S. Registration C-Guardian Clinical Trial of CGuard EPS
08:30am, Friday, 23'rd Jul 2021
TEL AVIV, Israel, July 23, 2021 (GLOBE NEWSWIRE) -- InspireMD, Inc. (Nasdaq: NSPR), developer of the CGuard™ Embolic Prevention Stent System (EPS) device for the treatment of Carotid Artery Disease
InspireMD to Present at the LD Micro Virtual Invitational Conference on June 9, 2021
08:04am, Wednesday, 02'nd Jun 2021
TEL AVIV, Israel, June 02, 2021 (GLOBE NEWSWIRE) -- InspireMD, Inc. (Nasdaq-CM: NSPR) developer of the CGuard™ Embolic Prevention System (EPS) for the prevention of stroke caused by Carotid Artery D
InspireMD Commences Trading on Nasdaq-CM
08:30am, Friday, 21'st May 2021
Ticker to remain NSPR Ticker to remain NSPR
InspireMD to Participate at the Investor Summit Conference and Present to Investors on May 17, 2021
06:00am, Friday, 14'th May 2021
TEL AVIV, Israel, May 14, 2021 (GLOBE NEWSWIRE) -- InspireMD, Inc. (NYSE American: NSPR) developer of the CGuard™ Embolic Prevention System (EPS) for the prevention of stroke caused by the treatment
InspireMD Announces Appointment of Katie Arnold to Board of Directors
06:00am, Wednesday, 12'th May 2021
TEL AVIV, Israel, May 12, 2021 (GLOBE NEWSWIRE) -- InspireMD, Inc. (NYSE American: NSPR), developer of the CGuard™ Embolic Prevention System (EPS) for the prevention of stroke caused by the treatmen
InspireMD, Inc. (NSPR) CEO Marvin Slosman on Q1 2021 Results - Earnings Call Transcript
11:26am, Tuesday, 11'th May 2021
InspireMD, Inc. (NSPR) CEO Marvin Slosman on Q1 2021 Results - Earnings Call Transcript
InspireMD Announces Stock Exchange Listing Transfer to Nasdaq
04:05pm, Monday, 10'th May 2021
Ticker to remain NSPR Ticker to remain NSPR
InspireMD Appoints Acclaimed Interventional Cardiologist Kenneth Rosenfield, MD as Chair of its Newly Formed Scientific Advisory Board
06:00am, Thursday, 29'th Apr 2021
TEL AVIV, Israel, April 29, 2021 (GLOBE NEWSWIRE) -- InspireMD, Inc. (NYSE American: NSPR), developer of the CGuard™ Embolic Prevention System (EPS) for the prevention of the stroke caused by caroti
PreMarket Prep Stock Of The Day: InspireMD
01:35pm, Tuesday, 27'th Apr 2021
Benzinga's PreMarket Prep airs every morning from 8-9 a.m. ET. During that fast-paced, highly informative hour, traders and investors tune in to get the major news of the day, the catalysts behind t
NSPR Stock: What You Should Know About InspireMD Today
08:40am, Tuesday, 27'th Apr 2021
InspireMD has vastly reduced the number of its shares trading ahead of a likely move to a Nasdaq listed. Conversion of NSPR stock warrants and preferred shares will be more difficult now.
